Strategy to Address Innovative Off-Label Medication Use in China: Grading Management

European Journal of Clinical Pharmacology - Germany
doi 10.1007/s00228-014-1729-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Off-Label Medication Prescribing Patterns in Pediatrics: An Update

Hospital pediatrics
MedicineChild HealthPediatricsPerinatology
2019English

«Off Label Use»: Nouvelles Recommandations

Bulletin des Médecins Suisses
2007English

Demographic and Neuropsychiatric Factors Associated With Off-Label Medication Use in Frontotemporal Dementia and Alzheimer’s Disease

Alzheimer Disease and Associated Disorders
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2014English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Methylphenidate Off-Label Use and Safety

SpringerPlus
Multidisciplinary
2014English

Off-Label Use in Lymphoma Patients in Switzerland

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Off-Label Use of Approved Drugs

Nature Reviews Clinical Oncology
Oncology
2009English

Off-Label Use of Omalizumab in Pediatric Anaphylaxis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Wheat Belt-Planting in China: An Innovative Strategy to Improve Production

Plant Production Science
AgronomyCrop Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy